The MnFe 2 O 4 component of MFC-GEM depletes GSH, increases ROS levels, and enables pH-responsive release of gemcitabine in vivo
& Vance, D
However, these studies cannot definitely establish or exclude the absence of drug-associated risk during pregnancy, because either the timing of the administration during gestation was not accurately ascertained or the administration only occurred during the second trimester
Several factors, including dosage, quantity injected, target region size, and maintenance dose, affect the total expense of these injections
OPA1, a key mitochondrial fusion regulator, is upregulated in multiple cancers, including AML and breast, colon, small cell lung, and stomach cancers (Fig
Functional Testing to Understand Your System We begin with deep, targeted testing